Literature DB >> 13797621

New antiviral chemotherapeutic agent active against smallpox infection.

D J BAUER, P W SADLER.   

Abstract

Entities:  

Keywords:  SMALLPOX/therapy; THIOSEMICARBAZONES/therapy

Mesh：

Substances：

Year:  1960        PMID： 13797621     DOI： 10.1016/s0140-6736(60)90990-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Prolonged generalized vaccinia complicating acute leukaemia.

Authors:  E DAVIDSON; F G HAYHOE
Journal:  Br Med J       Date:  1962-11-17

2.  A fatal case of progressive vaccinia.

Authors:  J H CONNOLLY; G W DICK; C M FIELD
Journal:  Br Med J       Date:  1962-05-12

3.  Case of malignant smallpox treated with compound 33T57.

Authors:  J P MARSDEN
Journal:  Br Med J       Date:  1962-08-25

Review 4.  New indications for 6-azauridine treatment in man. A review.

Authors:  J Elis; H Rasková
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

5.  Effect of N,N'-bis(methylisatin-beta-thiosemicarbazone)-2-methylpiperazine on vaccinia virus replication in vitro and in vivo. Brief report.

Authors:  J Borysiewicz; W Witaliński
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

6.  The chemotherapy of variola major infection.

Authors:  D J BAUER; K R DUMBELL; P FOX-HULME; P W SADLER
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

7.  Respiratory viruses. Current status and future prospects.

Authors:  D Rifkind
Journal:  Calif Med       Date:  1965-12

8.  Synthesis of thiocarbohydrazide and carbohydrazide derivatives as possible biologically active agents.

Authors:  Kiran Gangarapu; Sarangapani Manda; Anvesh Jallapally; Sreekanth Thota; Subhas S Karki; Jan Balzarini; Erik De Clercq; Harukuni Tokuda
Journal:  Med Chem Res       Date:  2013-08-23       Impact factor: 1.965
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.